New research reveals how tiny electrical gates in the brain, known as NMDA receptors, control learning, memory, and neuron ...
As information zings from cell to cell inside the brain, bursts of electricity spur its transmission. At Cold Spring Harbor ...
Growth fueled by the increasing incidence of Alzheimer's disease, growing aging population, and continued development in ...
In a recent study published in the journal Nature, researchers investigate whether persistent blocking of N-methyl-D-aspartate receptor (NMDAR) and burst-type firing by lateral habenula (LHb) neurons ...
Meanwhile, last week the Danish pharmaceutical powerhouse Novo Nordisk, which brought Ozempic into the spotlight, announced it would soon begin a human trial using the GLP-1 agonist drugs as a ...
Jan. 14 -- WEDNESDAY, Jan. 13 (HealthDay News) -- Reduced dosages of dopamine agonists, drugs routinely used to treat Parkinson's disease, can cause symptoms similar to those experienced by addicts in ...
Structure Therapeutics Inc. (GPCR) was able to report positive results from its phase 2a study using its GLP-1R agonist GSBR-1290 for the treatment of patients with obesity in June 2024. This is an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback